Appointment of Chief Executive Officer
Filed with ASX · · 3 pages · English
Summary by 6ix AI
Eve Health Group Limited has announced the appointment of Mr. Ben Rohr as Chief Executive Officer, effective immediately. Mr. Rohr previously served as Chief Operating Officer and has been key in the company's operational and commercial progress. Mr. Damian Wood will step down as CEO but will remain with the company as Head of Regulatory and Medical Affairs. The Board believes this leadership structure aligns well with the company's strategic priorities for growth and regulatory expertise.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
EVE Health Group Limited on 6ix
Story so far
Earlier from EVE Health
- Investor Presentation
- Prospectus
- EVE Placement Update
- EVE Raises $0.9m to Advance Drug Reformulation Strategy
- Trading Halt
Later from EVE Health
- Eve Initiates Pilot Clinical Study for Libbo ED Film
- Quarterly Activities/Appendix 4C Cash Flow Report
- Quarterly Activities/Appendix 4C Cash Flow Report - Amended
- Appendix 4E
- Annual Report to shareholders
Follow EVE Health into a list and get an email when it puts out news.
Follow EVE Health